ArticleThe Journal of pharmacology and experimental therapeutics2008

The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.

Tina C Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.